ESR1 and systemic lupus erythematosus: For example, studies have suggested that SLE patients had significantly higher levels of sex hormone binding globulin (SHBG) in comparison with the controls, resulting in decreased concentrations of bioavailable estrogen (the most potent estrogen receptor agonist), which may reduce the risk of endometrioid endometrial cancer (34).